ESTRO35 Programme Book

POSTERS

> Patient weight loss predicts worse overall survival for stage I lung cancer treated with SABR G. Cook (Canada), Y. Xu, P. Cross, O. Holmes, R. Macrae, J. Pantarotto > SABR for central lung tumors: plan quality and long-term clinical outcomes H. Tekatli (The Netherlands), S. Senan, M. Dahele, B.J. Slotman, W. Verbakel > A novel endoscopically injected liquid-gel marker for image guided radiotherapy of thoracic tumours S.R. Mortensen (Denmark), J. Scherman-Rydhög, K.R. Larsen, P.F. Clementsen, G.F. Persson, M. Aznar, M. Josipovic, P.M. Rosenschöld, R.I. Jølck, T.L. Andresen, L. Specht > Primary tumor response of locally advanced NSCLC in PET/CTs during radiochemotherapy T. Schimek-Jasch (Germany), S. Adebahr, M. Mix, A.L. Grosu, U. Nestle > Lung toxicity modelling in thoracic post-operative RT for NSCLC and pleural mesothelioma A. Botticella (Belgium), G. Defraene, C. Billiet, C. Draulans, K. Nackaerts, C. Deroose, J. Coolen, P. Nafteux, S. Peeters, D. De Ruysscher

PO-0690

PO-0691

PO-0692

PO-0693

PO-0694

> Lobectomy vs stereotactic ablative radiotherapy in NSCLC: a multicentric series in four centers

V. Scotti (Italy), A. Bruni, G. Simontacchi, I.F. Furfaro, M. Loi, D. Scartoni, A. Gonfiotti, D. Viggiano, C. De Luca Cardillo, B. Agresti, L. Poggesi, E. Olmetto, K. Ferrari, M. Perna, P. Bastiani, L. Paoletti, L. Lastrucci, P. Pernici, G. Carta, S. Borghesi, S. Bertocci, P. Giacobazzi, L. Voltolini, L. Livi

PO-0695

Poster CLINICAL TRACK: UPPER GI (OESOPHAGUS, STOMACH, PANCREAS, LIVER) > Prognostic impact of celiac/supraclavicular node metastasis in locally advanced oesophageal cancer W.K. Cho (Republic of Korea), D. Oh, Y.C. Ahn, H. Lee, Y.M. Shim, J.I. Zo, J.M. Sun, M.J. Ahn, K. Park > Neoadjuvant vs. adjuvant treatment of gastroesophageal junction cancer: a retrospective analysis A. Stessin (USA), J. Miccio, O. Oladeru, S. Ryu

PO-0696

PO-0697

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

169